Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // January 14th, 2010 // 7:01 am
Another day, another deadline. But this is a busy world, after all. And what better way to prepare than to keep up with events. So, as you gird for the challenges ahead, here are a few items to help you along. As for us, we will reach for our usual cup of stimulation. Have a good day, everyone…
FDA Issues New Guidance To IRBs On Multi-Site Trials (OutsourcingPharma)
US Pharmacopeia Recalls New Edition Of USP-NF (statement)
Glaxo Forms Global Media Team (PR Week)
Blood Pressure Drugs May Cut Dementia Risk (Bloomberg News)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Advair, AntiHypertensive Agents, AstraZeneca, Clinical Trials, Dementia, FDA, GlaxoSmithKline, High Blood Pressure, Institutional Review Boards, Merck, Sanofi Aventis